Structure

Physi-Chem Properties

Molecular Weight:  436.15
Volume:  435.977
LogP:  5.429
LogD:  3.61
LogS:  -3.252
# Rotatable Bonds:  1
TPSA:  109.36
# H-Bond Aceptor:  7
# H-Bond Donor:  3
# Rings:  5
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.502
Synthetic Accessibility Score:  3.987
Fsp3:  0.32
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  2
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.93
MDCK Permeability:  1.487992540205596e-05
Pgp-inhibitor:  0.998
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.079
20% Bioavailability (F20%):  0.001
30% Bioavailability (F30%):  0.008

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.01
Plasma Protein Binding (PPB):  98.31317138671875%
Volume Distribution (VD):  0.579
Pgp-substrate:  4.25582218170166%

ADMET: Metabolism

CYP1A2-inhibitor:  0.617
CYP1A2-substrate:  0.533
CYP2C19-inhibitor:  0.436
CYP2C19-substrate:  0.063
CYP2C9-inhibitor:  0.843
CYP2C9-substrate:  0.744
CYP2D6-inhibitor:  0.317
CYP2D6-substrate:  0.194
CYP3A4-inhibitor:  0.323
CYP3A4-substrate:  0.293

ADMET: Excretion

Clearance (CL):  1.707
Half-life (T1/2):  0.281

ADMET: Toxicity

hERG Blockers:  0.012
Human Hepatotoxicity (H-HT):  0.711
Drug-inuced Liver Injury (DILI):  0.98
AMES Toxicity:  0.291
Rat Oral Acute Toxicity:  0.49
Maximum Recommended Daily Dose:  0.86
Skin Sensitization:  0.627
Carcinogencity:  0.662
Eye Corrosion:  0.003
Eye Irritation:  0.717
Respiratory Toxicity:  0.713

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC165456

Natural Product ID:  NPC165456
Common Name*:   Broussonol B
IUPAC Name:   3,5-dihydroxy-2-(8-hydroxy-2,2-dimethylchromen-6-yl)-8,9,9-trimethyl-8H-furo[2,3-h]chromen-4-one
Synonyms:  
Standard InCHIKey:  WYEJSRSJEMZHNA-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C25H24O7/c1-11-25(4,5)18-16(30-11)10-14(26)17-19(28)20(29)22(31-23(17)18)13-8-12-6-7-24(2,3)32-21(12)15(27)9-13/h6-11,26-27,29H,1-5H3
SMILES:  CC1C(C)(C)c2c(cc(c3c(=O)c(c(c4cc5C=CC(C)(C)Oc5c(c4)O)oc23)O)O)O1
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL457086
PubChem CID:   10320815
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0003520] Pyranoflavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO16111 Broussonetia kazinoki Species Moraceae Eukaryota Leaves n.a. n.a. PMID[11575957]
NPO16111 Broussonetia kazinoki Species Moraceae Eukaryota n.a. n.a. n.a. PMID[19046886]
NPO16111 Broussonetia kazinoki Species Moraceae Eukaryota n.a. n.a. n.a. PMID[20493686]
NPO16111 Broussonetia kazinoki Species Moraceae Eukaryota n.a. n.a. n.a. PMID[9917310]
NPO16111 Broussonetia kazinoki Species Moraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO16111 Broussonetia kazinoki Species Moraceae Eukaryota n.a. n.a. n.a. Database[TM-MC]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT81 Cell Line A549 Homo sapiens ED50 = 5.52 ug ml-1 PMID[492206]
NPT180 Cell Line HCT-8 Homo sapiens ED50 = 8.8 ug ml-1 PMID[492206]
NPT91 Cell Line KB Homo sapiens ED50 > 10.0 ug ml-1 PMID[492206]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC165456 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9684 High Similarity NPC78332
0.9627 High Similarity NPC288813
0.962 High Similarity NPC187354
0.9557 High Similarity NPC476283
0.95 High Similarity NPC472625
0.9448 High Similarity NPC472276
0.9441 High Similarity NPC62261
0.9441 High Similarity NPC472277
0.9434 High Similarity NPC118256
0.9434 High Similarity NPC328102
0.9434 High Similarity NPC192686
0.9434 High Similarity NPC119209
0.9434 High Similarity NPC472624
0.9379 High Similarity NPC186686
0.9379 High Similarity NPC205265
0.9379 High Similarity NPC472281
0.9379 High Similarity NPC18100
0.9375 High Similarity NPC474038
0.9371 High Similarity NPC184755
0.9371 High Similarity NPC74178
0.9367 High Similarity NPC3980
0.9367 High Similarity NPC471985
0.9329 High Similarity NPC102277
0.9329 High Similarity NPC279209
0.9325 High Similarity NPC150131
0.9317 High Similarity NPC474162
0.9317 High Similarity NPC472635
0.9317 High Similarity NPC474150
0.9313 High Similarity NPC287328
0.9313 High Similarity NPC475784
0.9313 High Similarity NPC282009
0.9313 High Similarity NPC28241
0.9308 High Similarity NPC27337
0.9308 High Similarity NPC284820
0.9308 High Similarity NPC473272
0.9308 High Similarity NPC237418
0.9268 High Similarity NPC152477
0.9264 High Similarity NPC471213
0.9264 High Similarity NPC43319
0.9259 High Similarity NPC124038
0.9259 High Similarity NPC472582
0.9259 High Similarity NPC476295
0.9255 High Similarity NPC472632
0.9255 High Similarity NPC471210
0.9255 High Similarity NPC234644
0.9255 High Similarity NPC173137
0.9255 High Similarity NPC471499
0.9255 High Similarity NPC57715
0.9255 High Similarity NPC289771
0.9255 High Similarity NPC26326
0.925 High Similarity NPC22192
0.925 High Similarity NPC280680
0.9245 High Similarity NPC35038
0.9245 High Similarity NPC195796
0.9245 High Similarity NPC170026
0.9245 High Similarity NPC282307
0.9245 High Similarity NPC278778
0.9245 High Similarity NPC291878
0.9241 High Similarity NPC170492
0.9207 High Similarity NPC476306
0.9207 High Similarity NPC218226
0.9202 High Similarity NPC293319
0.9202 High Similarity NPC300053
0.9202 High Similarity NPC108433
0.9202 High Similarity NPC224280
0.9202 High Similarity NPC303174
0.9198 High Similarity NPC474034
0.9198 High Similarity NPC474033
0.9198 High Similarity NPC194427
0.9198 High Similarity NPC81679
0.9198 High Similarity NPC261470
0.9193 High Similarity NPC470326
0.9193 High Similarity NPC174953
0.9193 High Similarity NPC297212
0.9193 High Similarity NPC470183
0.9193 High Similarity NPC476280
0.9193 High Similarity NPC188433
0.9193 High Similarity NPC36217
0.9187 High Similarity NPC471515
0.9187 High Similarity NPC471209
0.9187 High Similarity NPC67876
0.9187 High Similarity NPC472598
0.9187 High Similarity NPC474055
0.9187 High Similarity NPC52889
0.9187 High Similarity NPC291508
0.9187 High Similarity NPC78071
0.9187 High Similarity NPC471479
0.9182 High Similarity NPC234255
0.9182 High Similarity NPC470327
0.9182 High Similarity NPC45849
0.9182 High Similarity NPC200761
0.9182 High Similarity NPC477503
0.9182 High Similarity NPC133392
0.9177 High Similarity NPC37684
0.9177 High Similarity NPC157784
0.9177 High Similarity NPC471982
0.9177 High Similarity NPC63187
0.9157 High Similarity NPC121333
0.9152 High Similarity NPC177480
0.9152 High Similarity NPC242395
0.9146 High Similarity NPC170245
0.9146 High Similarity NPC235610
0.9146 High Similarity NPC272502
0.9141 High Similarity NPC473313
0.9141 High Similarity NPC12461
0.9141 High Similarity NPC306321
0.9141 High Similarity NPC329669
0.9141 High Similarity NPC472278
0.9141 High Similarity NPC41301
0.9141 High Similarity NPC303460
0.9136 High Similarity NPC471211
0.9136 High Similarity NPC471212
0.9136 High Similarity NPC134783
0.9136 High Similarity NPC472634
0.9136 High Similarity NPC198829
0.9136 High Similarity NPC259456
0.913 High Similarity NPC46736
0.913 High Similarity NPC117418
0.913 High Similarity NPC204879
0.913 High Similarity NPC55738
0.913 High Similarity NPC53545
0.913 High Similarity NPC187792
0.913 High Similarity NPC473990
0.913 High Similarity NPC197856
0.913 High Similarity NPC469658
0.9125 High Similarity NPC209614
0.9125 High Similarity NPC326037
0.9125 High Similarity NPC320825
0.9125 High Similarity NPC472626
0.9125 High Similarity NPC470328
0.9125 High Similarity NPC471500
0.9125 High Similarity NPC472455
0.9125 High Similarity NPC13858
0.9125 High Similarity NPC276444
0.9119 High Similarity NPC192083
0.9119 High Similarity NPC18727
0.9119 High Similarity NPC213896
0.9119 High Similarity NPC270620
0.9119 High Similarity NPC78326
0.9119 High Similarity NPC74924
0.9119 High Similarity NPC236223
0.9119 High Similarity NPC179126
0.9114 High Similarity NPC252933
0.9114 High Similarity NPC59162
0.9114 High Similarity NPC200740
0.9114 High Similarity NPC54394
0.9114 High Similarity NPC471675
0.9114 High Similarity NPC304295
0.9114 High Similarity NPC205046
0.9114 High Similarity NPC125062
0.9102 High Similarity NPC310794
0.9096 High Similarity NPC101107
0.9091 High Similarity NPC158761
0.9091 High Similarity NPC8965
0.9085 High Similarity NPC470457
0.9085 High Similarity NPC234052
0.9085 High Similarity NPC275780
0.9085 High Similarity NPC239752
0.9085 High Similarity NPC326520
0.9085 High Similarity NPC472450
0.9085 High Similarity NPC475888
0.9085 High Similarity NPC473286
0.9085 High Similarity NPC50960
0.908 High Similarity NPC206605
0.908 High Similarity NPC211107
0.908 High Similarity NPC201800
0.908 High Similarity NPC83922
0.908 High Similarity NPC476247
0.908 High Similarity NPC472448
0.9074 High Similarity NPC204290
0.9074 High Similarity NPC476980
0.9074 High Similarity NPC474960
0.9074 High Similarity NPC472630
0.9074 High Similarity NPC472631
0.9074 High Similarity NPC246478
0.9074 High Similarity NPC471973
0.9068 High Similarity NPC187745
0.9068 High Similarity NPC161960
0.9068 High Similarity NPC304008
0.9068 High Similarity NPC180011
0.9068 High Similarity NPC52530
0.9068 High Similarity NPC273843
0.9068 High Similarity NPC218871
0.9068 High Similarity NPC218313
0.9068 High Similarity NPC223787
0.9068 High Similarity NPC476630
0.9068 High Similarity NPC474681
0.9068 High Similarity NPC219867
0.9062 High Similarity NPC304207
0.9062 High Similarity NPC259710
0.9062 High Similarity NPC321779
0.9062 High Similarity NPC476169
0.9062 High Similarity NPC207809
0.9062 High Similarity NPC217706
0.9062 High Similarity NPC472280
0.9062 High Similarity NPC226025
0.9062 High Similarity NPC471116
0.9062 High Similarity NPC48579
0.9057 High Similarity NPC236637
0.9057 High Similarity NPC55205

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC165456 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9119 High Similarity NPD2393 Clinical (unspecified phase)
0.9057 High Similarity NPD1934 Approved
0.9006 High Similarity NPD3882 Suspended
0.897 High Similarity NPD6166 Phase 2
0.897 High Similarity NPD6167 Clinical (unspecified phase)
0.897 High Similarity NPD6168 Clinical (unspecified phase)
0.8882 High Similarity NPD2801 Approved
0.8797 High Similarity NPD1512 Approved
0.875 High Similarity NPD3818 Discontinued
0.8734 High Similarity NPD4378 Clinical (unspecified phase)
0.8727 High Similarity NPD5494 Approved
0.8712 High Similarity NPD3817 Phase 2
0.8671 High Similarity NPD1511 Approved
0.8596 High Similarity NPD6797 Phase 2
0.8588 High Similarity NPD7054 Approved
0.858 High Similarity NPD4380 Phase 2
0.8547 High Similarity NPD7251 Discontinued
0.8538 High Similarity NPD7472 Approved
0.8538 High Similarity NPD7074 Phase 3
0.8497 Intermediate Similarity NPD7808 Phase 3
0.8497 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8494 Intermediate Similarity NPD7075 Discontinued
0.8424 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8372 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8364 Intermediate Similarity NPD6801 Discontinued
0.8323 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8274 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8272 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8263 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8242 Intermediate Similarity NPD6599 Discontinued
0.8235 Intermediate Similarity NPD1247 Approved
0.8225 Intermediate Similarity NPD919 Approved
0.8187 Intermediate Similarity NPD6232 Discontinued
0.8176 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8176 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8161 Intermediate Similarity NPD5844 Phase 1
0.8155 Intermediate Similarity NPD5402 Approved
0.815 Intermediate Similarity NPD7473 Discontinued
0.8129 Intermediate Similarity NPD6959 Discontinued
0.8125 Intermediate Similarity NPD1549 Phase 2
0.8113 Intermediate Similarity NPD2796 Approved
0.8098 Intermediate Similarity NPD6799 Approved
0.8095 Intermediate Similarity NPD7819 Suspended
0.8075 Intermediate Similarity NPD2800 Approved
0.8068 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8061 Intermediate Similarity NPD5403 Approved
0.805 Intermediate Similarity NPD1510 Phase 2
0.8035 Intermediate Similarity NPD3926 Phase 2
0.8023 Intermediate Similarity NPD6559 Discontinued
0.7976 Intermediate Similarity NPD7411 Suspended
0.7939 Intermediate Similarity NPD5401 Approved
0.7882 Intermediate Similarity NPD1465 Phase 2
0.7845 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7831 Intermediate Similarity NPD2532 Approved
0.7831 Intermediate Similarity NPD2534 Approved
0.7831 Intermediate Similarity NPD2533 Approved
0.7799 Intermediate Similarity NPD1240 Approved
0.7791 Intermediate Similarity NPD7768 Phase 2
0.7784 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7746 Intermediate Similarity NPD3749 Approved
0.7727 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7705 Intermediate Similarity NPD8434 Phase 2
0.7702 Intermediate Similarity NPD1607 Approved
0.7701 Intermediate Similarity NPD6234 Discontinued
0.7697 Intermediate Similarity NPD3750 Approved
0.7697 Intermediate Similarity NPD4628 Phase 3
0.7688 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7688 Intermediate Similarity NPD1613 Approved
0.7688 Intermediate Similarity NPD943 Approved
0.7683 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.768 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7634 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7633 Intermediate Similarity NPD920 Approved
0.7633 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7622 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7614 Intermediate Similarity NPD7199 Phase 2
0.761 Intermediate Similarity NPD3027 Phase 3
0.7598 Intermediate Similarity NPD3751 Discontinued
0.7571 Intermediate Similarity NPD3787 Discontinued
0.7561 Intermediate Similarity NPD2935 Discontinued
0.7561 Intermediate Similarity NPD6099 Approved
0.7561 Intermediate Similarity NPD6100 Approved
0.7547 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.753 Intermediate Similarity NPD1243 Approved
0.753 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7515 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7514 Intermediate Similarity NPD37 Approved
0.75 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7228 Approved
0.75 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7486 Intermediate Similarity NPD4965 Approved
0.7486 Intermediate Similarity NPD4967 Phase 2
0.7486 Intermediate Similarity NPD4966 Approved
0.7485 Intermediate Similarity NPD6651 Approved
0.7484 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7474 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7456 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7448 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.744 Intermediate Similarity NPD6190 Approved
0.7432 Intermediate Similarity NPD7685 Pre-registration
0.7423 Intermediate Similarity NPD230 Phase 1
0.7412 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.741 Intermediate Similarity NPD2344 Approved
0.7409 Intermediate Similarity NPD2493 Approved
0.7409 Intermediate Similarity NPD2494 Approved
0.7394 Intermediate Similarity NPD3748 Approved
0.7381 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD4363 Phase 3
0.7368 Intermediate Similarity NPD4360 Phase 2
0.7358 Intermediate Similarity NPD6778 Approved
0.7358 Intermediate Similarity NPD6779 Approved
0.7358 Intermediate Similarity NPD6782 Approved
0.7358 Intermediate Similarity NPD6776 Approved
0.7358 Intermediate Similarity NPD6781 Approved
0.7358 Intermediate Similarity NPD6777 Approved
0.7358 Intermediate Similarity NPD6780 Approved
0.7353 Intermediate Similarity NPD7390 Discontinued
0.7349 Intermediate Similarity NPD1551 Phase 2
0.7346 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7346 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7341 Intermediate Similarity NPD3226 Approved
0.7326 Intermediate Similarity NPD8150 Discontinued
0.732 Intermediate Similarity NPD3450 Approved
0.732 Intermediate Similarity NPD3452 Approved
0.7317 Intermediate Similarity NPD447 Suspended
0.7296 Intermediate Similarity NPD4582 Approved
0.7296 Intermediate Similarity NPD4583 Approved
0.7293 Intermediate Similarity NPD2403 Approved
0.7289 Intermediate Similarity NPD2799 Discontinued
0.7289 Intermediate Similarity NPD7033 Discontinued
0.7289 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7283 Intermediate Similarity NPD1653 Approved
0.7283 Intermediate Similarity NPD5953 Discontinued
0.7278 Intermediate Similarity NPD5710 Approved
0.7278 Intermediate Similarity NPD5711 Approved
0.7268 Intermediate Similarity NPD7286 Phase 2
0.7268 Intermediate Similarity NPD7907 Approved
0.7258 Intermediate Similarity NPD8312 Approved
0.7258 Intermediate Similarity NPD8313 Approved
0.7255 Intermediate Similarity NPD4665 Approved
0.7255 Intermediate Similarity NPD4111 Phase 1
0.7245 Intermediate Similarity NPD4002 Approved
0.7245 Intermediate Similarity NPD4004 Approved
0.7245 Intermediate Similarity NPD7435 Discontinued
0.7241 Intermediate Similarity NPD7458 Discontinued
0.724 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.724 Intermediate Similarity NPD4361 Phase 2
0.7239 Intermediate Similarity NPD2313 Discontinued
0.7235 Intermediate Similarity NPD2309 Approved
0.7222 Intermediate Similarity NPD8127 Discontinued
0.7222 Intermediate Similarity NPD7584 Approved
0.7222 Intermediate Similarity NPD4908 Phase 1
0.7212 Intermediate Similarity NPD6355 Discontinued
0.7212 Intermediate Similarity NPD5124 Phase 1
0.7212 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7211 Intermediate Similarity NPD2488 Approved
0.7211 Intermediate Similarity NPD2490 Approved
0.7209 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7202 Intermediate Similarity NPD2974 Approved
0.7202 Intermediate Similarity NPD2975 Approved
0.7202 Intermediate Similarity NPD2346 Discontinued
0.7202 Intermediate Similarity NPD2973 Approved
0.7182 Intermediate Similarity NPD7229 Phase 3
0.7176 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7175 Intermediate Similarity NPD5761 Phase 2
0.7175 Intermediate Similarity NPD5760 Phase 2
0.716 Intermediate Similarity NPD9494 Approved
0.7157 Intermediate Similarity NPD7698 Approved
0.7157 Intermediate Similarity NPD7697 Approved
0.7157 Intermediate Similarity NPD7696 Phase 3
0.7152 Intermediate Similarity NPD4060 Phase 1
0.7134 Intermediate Similarity NPD6798 Discontinued
0.7125 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7121 Intermediate Similarity NPD7871 Phase 2
0.7121 Intermediate Similarity NPD7870 Phase 2
0.7108 Intermediate Similarity NPD1933 Approved
0.7104 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.71 Intermediate Similarity NPD7701 Phase 2
0.7098 Intermediate Similarity NPD6534 Approved
0.7098 Intermediate Similarity NPD6535 Approved
0.7092 Intermediate Similarity NPD4580 Approved
0.7076 Intermediate Similarity NPD4110 Phase 3
0.7076 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7073 Intermediate Similarity NPD7095 Approved
0.7073 Intermediate Similarity NPD4625 Phase 3
0.7069 Intermediate Similarity NPD6273 Approved
0.7065 Intermediate Similarity NPD8151 Discontinued
0.7059 Intermediate Similarity NPD2424 Discontinued
0.7059 Intermediate Similarity NPD7240 Approved
0.7049 Intermediate Similarity NPD5242 Approved
0.7045 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.703 Intermediate Similarity NPD7874 Approved
0.703 Intermediate Similarity NPD3268 Approved
0.703 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.703 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7027 Intermediate Similarity NPD2163 Approved
0.702 Intermediate Similarity NPD2491 Approved
0.702 Intermediate Similarity NPD3057 Approved
0.7006 Intermediate Similarity NPD7028 Phase 2
0.7 Intermediate Similarity NPD1547 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data